Filing Details
- Accession Number:
- 0001209191-21-046802
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-15 17:33:47
- Reporting Period:
- 2021-07-14
- Accepted Time:
- 2021-07-15 17:33:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1637715 | Reneo Pharmaceuticals Inc. | RPHM | Pharmaceutical Preparations (2834) | 472309515 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1652822 | S. Wendy Johnson | C/O Reneo Pharmaceuticals, Inc. 12230 El Camino Real, Suite 230 San Diego CA 92130 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-07-14 | 111,736 | $8.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The Reporting Person previously notified the Issuer of her intention to retire from her position as the Issuer's Chief Development Officer, effective on or before December 31, 2021. Following her announcement, the Reporting Person exercised an option totaling 111,736 shares of Common Stock of the Issuer (the "Shares") on July 8, 2021. The Reporting Person is selling the Shares privately to Abingworth Bioventures 8 LP ("Abingworth"), an existing stockholder of the Issuer. Bali Muralidhar, a Director of the Issuer, is a member of the investment committee of Abingworth.
Billionaire Hedge Funds
